Overview
TOI market data
Price History
TOI price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.66 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.37 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.32 – $6.67 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $506.9 · P/B 6.51 · P/S 0.93.
Company News
BTIG Maintains Buy on Oncology Institute, Raises Price Target to $9Benzinga · Jul 9, 2026, 5:55 PM
Lake Street Initiates Coverage On Oncology Institute with Buy Rating, Announces Price Target of $10Benzinga · Jul 6, 2026, 3:55 PM
Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For MondayBenzinga · Jun 8, 2026, 1:55 PM
Oncology Institute Says In Follow Up To Nov 2025 Disclosure Of A Cybersecurity Incident, Says A Software Service Provider Detected Unauthorized Access; Vendor Had Unauthorized Access To Information Systems Including Patient Data; Cybersecurity Incident Believed To Affect Other Healthcare Providers; Patient Portal Established; Operations Continue In All Material Respects Since Incident DetectionBenzinga · May 22, 2026, 8:55 PM